1. Home
  2. ORGO vs CINT Comparison

ORGO vs CINT Comparison

Compare ORGO & CINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

HOLD

Current Price

$2.89

Market Cap

514.0M

Sector

Health Care

ML Signal

HOLD

Logo CI&T Inc

CINT

CI&T Inc

HOLD

Current Price

$5.15

Market Cap

566.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORGO
CINT
Founded
1985
1995
Country
United States
Brazil
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
514.0M
566.6M
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
ORGO
CINT
Price
$2.89
$5.15
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$7.67
$6.80
AVG Volume (30 Days)
560.8K
117.2K
Earning Date
05-29-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
1600.00
N/A
EPS
0.15
N/A
Revenue
$564,169,000.00
N/A
Revenue This Year
N/A
$13.00
Revenue Next Year
$10.07
$12.62
P/E Ratio
$19.03
$17.94
Revenue Growth
17.04
N/A
52 Week Low
$2.61
$3.98
52 Week High
$7.08
$7.10

Technical Indicators

Market Signals
Indicator
ORGO
CINT
Relative Strength Index (RSI) 25.88 60.98
Support Level $2.88 $4.93
Resistance Level $3.28 $5.24
Average True Range (ATR) 0.23 0.19
MACD -0.09 0.02
Stochastic Oscillator 5.64 93.85

Price Performance

Historical Comparison
ORGO
CINT

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

About CINT CI&T Inc

CI&T Inc is engaged in providing plans, design, and software engineering services to enable digital transformation for companies. The company mainly develops customizable software through the implementation of several software solutions, including Machine Learning, Artificial Intelligence (AI), Analytics, Cloud, and Mobility technologies. The majority of the revenue is generated from the North America and Europe, followed by Asia, Pacific and Japan.

Share on Social Networks: